Clinical Trials Logo

Clinical Trial Summary

The specific aim for our study is to measure coagulation system activation and fibrinolysis following transdermal versus sublingual versus oral estradiol versus in transgender women. Hypothesis: Transdermal estradiol will result in less coagulation system activation and no effect on plasminogen activator inhibitor (PAI-1) or tissue-type plasminogen activator (t-PA). Oral estradiol will result in the most coagulation system activation and effect on PAI-1 and t-PA: Oral estradiol > sublingual estradiol > transdermal estradiol. A prospective crossover study will include ten subjects given estradiol 1 mg daily and instructed to take it orally, sublingually, or transdermal for 2 months with a 2-week washout period between routes of administration. Labs will be measured 7 times during the study.


Clinical Trial Description

Subjects will report to our Adult Translational Research Unit for labs at baseline (2 weeks after HRT washout if needed). Both fibrinolysis and testosterone labs have a diurnal variation. Therefore, fasting labs will be drawn at approximately 8 AM. Five subjects will start oral estradiol and 5 will start sublingual estradiol for 8 weeks. Froedtert's Pharmacy Investigational Drug Service will provide the study estradiol. There will be a 2-week washout period between treatment periods. Fasting labs will be drawn at approximately 8 AM prior to Treatment Period 2. The groups will switch therapy. Those that took oral estradiol during Treatment Period 1 will take sublingual estradiol for 8 weeks. Those that took sublingual estradiol during Treatment Period 1 will take oral estradiol for 8 weeks. Finally, all subjects will start the transdermal for 8 weeks for Treatment Period 3. Final set of labs will be drawn at approximately 8 AM 2 weeks after Treatment Period 3. The investigators will call subjects every 2 weeks to assess their adherence to the treatment protocol and remind them of the importance of allowing the tablet to dissolve when taking estradiol sublingually. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05387577
Study type Interventional
Source Medical College of Wisconsin
Contact
Status Terminated
Phase Early Phase 1
Start date December 7, 2021
Completion date November 23, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT06093724 - Prospective Imaging Assessment of Perineo-pelvic Static's Evolution After Sexual Reassignment Surgery in MtF Transgender Patient, by Peno-scrotal Inversion Vaginoplasty Technique (TRANSPELV) N/A
Recruiting NCT04977765 - Cardiometabolic Health in Transgender Males
Recruiting NCT06074796 - The Determinants of Fertility Preservation in TRANSgender Patients.
Completed NCT04454970 - Safe Access for Bladder Entry in Transgender Men Following Penile Reconstruction N/A
Completed NCT04708600 - Effectiveness of Speech Therapy in Trans Women. N/A
Terminated NCT04551144 - Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors
Completed NCT04545450 - Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in Transmen Phase 3
Recruiting NCT05663892 - Drug-Drug Interaction Study in Trans Women Living With HIV Phase 4
Completed NCT05666102 - Transgender Men's Perspectives on HIV Risk and HIV Prevention Interventions N/A
Recruiting NCT04838249 - Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
Not yet recruiting NCT06434805 - An Education Initiative to Reduce Stigma Towards Sex Workers and Sexual Minorities Among Nursing Students N/A
Recruiting NCT05883553 - Epithesis Versus Prosthesis in Post-phalloplasty Transgender Patients. N/A
Not yet recruiting NCT04154358 - Implementing HPV DNA Self-Collection to Increase Rates of Cervical Cancer Screening in Transgender Men N/A
Recruiting NCT04254354 - Transgender Men, Non-binary Persons and Testosterone Treatment BODY IDENTITY CLINIC
Completed NCT04969003 - Reducing Transphobia Among Adolescents Through a Brief Video Intervention N/A
Completed NCT06149065 - Factors Associated With the Acne Severity Among Transmen Population: a Cross-sectional Study
Not yet recruiting NCT06443164 - Efficacy of a Chronic Pain Treatment Prior to Gender-affirming Surgery N/A
Not yet recruiting NCT06450405 - Androgen Effects on the Reproductive Neuroendocrine Axis
Terminated NCT04275310 - Microeconomic Intervention to Reduce HIV Transmission in Economically Disadvantaged Transgender Women N/A
Not yet recruiting NCT05415930 - Evaluation of an Adaptative, Multidisciplinary, Reach-out Program, Facilitating Pre Exposition HIV Prophylaxis (PrEP) Prescription and Retention in Care, in a Group of Trans Womens (TW) at High Risk of HIV Infection.